MA
Modus Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-333
| Closed | -$8.83K | – | 242 |
|
|
2024
Q4 | $8.83K | Buy |
+333
| New | +$8.83K | ﹤0.01% | 228 |
|
|
2024
Q1 | – | Sell |
-45,290
| Closed | -$1.3M | – | 105 |
|
|
2023
Q4 | $1.3M | Sell |
45,290
-11,442
| -20% | -$329K | 0.53% | 52 |
|
|
2023
Q3 | $1.88M | Sell |
56,732
-1,067
| -2% | -$35.4K | 0.82% | 44 |
|
|
2023
Q2 | $2.12M | Buy |
57,799
+4,589
| +9% | +$168K | 0.91% | 44 |
|
|
2023
Q1 | $2.17M | Buy |
53,210
+679
| +1% | +$27.7K | 1% | 42 |
|
|
2022
Q4 | $2.69M | Buy |
52,531
+2,903
| +6% | +$149K | 1.3% | 29 |
|
|
2022
Q3 | $2.17M | Buy |
49,628
+236
| +0.5% | +$10.3K | 1.14% | 30 |
|
|
2022
Q2 | $2.59M | Buy |
49,392
+1,520
| +3% | +$79.7K | 1.31% | 27 |
|
|
2022
Q1 | $2.48M | Buy |
47,872
+232
| +0.5% | +$12K | 1.09% | 31 |
|
|
2021
Q4 | $2.81M | Sell |
47,640
-668
| -1% | -$39.4K | 1.2% | 31 |
|
|
2021
Q3 | $2.08M | Buy |
48,308
+1,548
| +3% | +$66.6K | 0.9% | 38 |
|
|
2021
Q2 | $1.83M | Buy |
46,760
+1,778
| +4% | +$69.6K | 0.77% | 42 |
|
|
2021
Q1 | $1.63M | Buy |
44,982
+4,142
| +10% | +$150K | 0.76% | 46 |
|
|
2020
Q4 | $1.5M | Buy |
40,840
+3,399
| +9% | +$50.7K | 0.78% | 43 |
|
|
2020
Q3 | $1.37M | Buy |
37,441
+8,983
| +32% | +$330K | 0.79% | 42 |
|
|
2020
Q2 | $931K | Buy |
28,458
+11,477
| +68% | +$375K | 0.61% | 45 |
|
|
2020
Q1 | $554K | Buy |
16,981
+3,264
| +24% | +$106K | 0.51% | 34 |
|
|
2019
Q4 | $537K | Buy |
+13,717
| New | +$537K | 0.42% | 43 |
|